Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hawaii Biotech, Inc.
Hawaii Biotech Initiates Phase 1 Clinical Trial for West Nile Vaccine
July 16th, 2008
Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D., announced that the company has initiated a Phase 1 clinical trial study with its West Nile vaccine candidate. The study, being conducted with healthy subjects, is the first clinical trial for the company. "This clinical study is an important milestone in Hawaii Biotech's maturation into a clinical stage company," Parks notes. West Nile Virus (WNV), spread by exposure to infected mosquitoes, can cause serious, life-altering and even fatal disease. The most serious manifestation of WNV infection is fatal encephalitis. According to the Centers for Disease Control and Prevention, cases of WNV...
Source: Vaccine Weekly (2008-07-16)
|
